$JTAI
Jet.AI Inc.

2024 Q3 Form 10-Q Financial Statement

#000149315224032244 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $3.917M $3.084M $2.793M
YoY Change 16.34% 10.42%
Cost Of Revenue $3.931M $3.501M $2.994M
YoY Change 22.98% 16.94%
Gross Profit -$13.89K -$417.0K -$200.8K
YoY Change -108.15% 107.65%
Gross Profit Margin -0.35% -13.52% -7.19%
Selling, General & Admin $2.830M $2.766M $2.219M
YoY Change -35.51% 24.65% 2906.71%
% of Gross Profit
Research & Development $37.96K $37.40K $28.64K
YoY Change -22.25% 30.57%
% of Gross Profit
Depreciation & Amortization $33.82K $33.59K
YoY Change 0.68%
% of Gross Profit
Operating Expenses $2.868M $2.804M $2.248M
YoY Change -35.36% 24.72% 2945.5%
Operating Profit -$2.882M -$3.221M -$105.9K
YoY Change -32.45% 2940.75% 43.49%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $56.00 $59.00 $0.00
YoY Change -100.23%
Pretax Income -$2.882M -$3.221M -$2.449M
YoY Change -32.83% 31.52% 388.28%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.882M -$3.221M $232.3K
YoY Change -32.83% -1486.2% -146.33%
Net Earnings / Revenue -73.57% -104.43% 8.32%
Basic Earnings Per Share -$43.82 -$0.25 $0.06
Diluted Earnings Per Share -$43.82 -$0.25 $0.06
COMMON SHARES
Basic Shares Outstanding 24.58M shares 12.72M shares 4.177M shares
Diluted Shares Outstanding 78.52K shares 12.91M shares 4.177M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $528.1K $13.15M
YoY Change -95.98% 3037.54%
Cash & Equivalents $311.9K $528.1K $19.88K
Short-Term Investments $13.13M
Other Short-Term Assets $78.40K $72.77K $186.0K
YoY Change -50.35% -60.87% 198.64%
Inventory
Prepaid Expenses
Receivables $167.7K $536.0K
Other Receivables $0.00
Total Short-Term Assets $1.186M $1.937M $824.2K
YoY Change -42.65% 134.99% 71.27%
LONG-TERM ASSETS
Property, Plant & Equipment $5.692K $6.329K $1.838M
YoY Change -30.93% -99.66%
Goodwill
YoY Change
Intangibles $86.75K $20.40K
YoY Change 1.41%
Long-Term Investments $208.5K $158.4K
YoY Change 31.64%
Other Assets $689.8K $689.8K
YoY Change 0.0% -99.41%
Total Long-Term Assets $2.171M $2.237M $12.36M
YoY Change -19.37% -81.9% -89.41%
TOTAL ASSETS
Total Short-Term Assets $1.186M $1.937M $824.2K
Total Long-Term Assets $2.171M $2.237M $12.36M
Total Assets $3.357M $4.174M $13.18M
YoY Change -29.48% -68.33% -88.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.828M $1.515M $497.7K
YoY Change -36.54% 204.43%
Accrued Expenses $3.050M $2.749M $410.8K
YoY Change 269.44% 569.15% 2804.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.607M $5.881M $2.863M
YoY Change 7.15% 105.41% 20143.42%
LONG-TERM LIABILITIES
Long-Term Debt $1.702M $0.00
YoY Change
Other Long-Term Liabilities $760.5K $1.278M
YoY Change -40.5% -84.22%
Total Long-Term Liabilities $2.463M $1.278M
YoY Change 92.65% -84.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.607M $5.881M $2.863M
Total Long-Term Liabilities $2.463M $1.278M
Total Liabilities $8.385M $8.344M $5.587M
YoY Change -7.01% 49.36% -31.16%
SHAREHOLDERS EQUITY
Retained Earnings -$49.14M -$45.72M -$5.530M
YoY Change 36.08% 726.73% 714.9%
Common Stock $14.00 $1.475K
YoY Change -98.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.028M -$4.170M -$5.530M
YoY Change
Total Liabilities & Shareholders Equity $3.357M $4.174M $13.18M
YoY Change -29.48% -68.33% -88.75%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$2.882M -$3.221M $232.3K
YoY Change -32.83% -1486.2% -146.33%
Depreciation, Depletion And Amortization $33.82K $33.59K
YoY Change 0.68%
Cash From Operating Activities -$2.185M -$727.2K
YoY Change 200.43% 437.02%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $12.88K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$100.00 -$15.14K
YoY Change -99.34%
Cash From Investing Activities -$100.00 -$28.02K
YoY Change -99.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.449M 1.152M
YoY Change 25.77%
NET CHANGE
Cash From Operating Activities -2.185M -727.2K
Cash From Investing Activities -100.0 -28.02K
Cash From Financing Activities 1.449M 1.152M
Net Change In Cash -736.2K -755.2K
YoY Change -2.52% 457.71%
FREE CASH FLOW
Cash From Operating Activities -$2.185M -$727.2K
Capital Expenditures $0.00 $12.88K
Free Cash Flow -$2.185M -$740.1K
YoY Change 195.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24576880 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
528117 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
535975 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
72769 usd
CY2024Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
800000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6932482 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4668316 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
3500880 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
2993631 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
JTAI Subscription Receivable From Sale Of Common Stock
SubscriptionReceivableFromSaleOfCommonStock
usd
CY2024Q2 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2023Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2100543 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
96539 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
190071 usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
800000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
1936861 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3187153 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6329 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7604 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20401 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
73831 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1312332 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1572489 usd
CY2024Q2 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
100000 usd
CY2023Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
100000 usd
CY2024Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
798211 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
798111 usd
CY2024Q2 us-gaap Assets
Assets
4174134 usd
CY2023Q4 us-gaap Assets
Assets
5739188 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1515201 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1656965 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2749030 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2417115 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1099466 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1779794 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
517733 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
510034 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5881430 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6951897 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
760524 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1021330 usd
CY2024Q2 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
1702000 usd
CY2023Q4 us-gaap Preferred Stock Redemption Amount
PreferredStockRedemptionAmount
1702000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
8343954 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9675227 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14755144 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14755144 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9754364 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9754364 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1475 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
975 usd
CY2024Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
6724 usd
CY2023Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
6724 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41557422 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
35342098 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45721993 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39272388 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-4169820 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3936039 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4174134 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5739188 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3083884 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2792808 usd
us-gaap Cost Of Revenue
CostOfRevenue
7473834 usd
us-gaap Cost Of Revenue
CostOfRevenue
4944157 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
-416996 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-200823 usd
us-gaap Gross Profit
GrossProfit
-541352 usd
us-gaap Gross Profit
GrossProfit
-275841 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1348043 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2401046 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2755087 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2663753 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2115704 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5210047 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4603722 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
102470 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
103541 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
549070 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
223708 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37396 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28636 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
69942 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64955 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2803619 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2247881 usd
us-gaap Operating Expenses
OperatingExpenses
5829059 usd
us-gaap Operating Expenses
OperatingExpenses
4892385 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3220615 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2448704 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6370411 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5168226 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
79314 usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
59 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
120 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
59 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-79194 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3220556 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2448704 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6449605 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5168226 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3220556 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2448704 usd
us-gaap Net Income Loss
NetIncomeLoss
-6449605 usd
us-gaap Net Income Loss
NetIncomeLoss
-5168226 usd
CY2024Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
29727 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
59455 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5168226 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12906352 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12906352 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4520625 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4520625 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12224502 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12224502 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4511751 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4511751 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
736293 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1407044 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1512260 usd
CY2023Q1 JTAI Stock Issued During Period Value Receipt Of Subscription Receivable
StockIssuedDuringPeriodValueReceiptOfSubscriptionReceivable
76435 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
436969 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2719522 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
575541 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1348043 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2448704 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-525120 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3936039 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1199318 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
1500025 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
155000 usd
CY2024Q1 JTAI Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
742474 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1110000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3229049 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-2768271 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-2768271 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1201728 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
617279 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3220556 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-4169820 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-4169820 usd
us-gaap Net Income Loss
NetIncomeLoss
-6449605 usd
us-gaap Net Income Loss
NetIncomeLoss
-5168226 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
67626 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
67192 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
80761 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2401046 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2755087 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
260157 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
252686 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
439436 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-117302 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-171876 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-141764 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
254773 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
331915 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-173160 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-680328 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
166182 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-253107 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-245636 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4705433 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1919226 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4340 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12921 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
17174 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
100000 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
100 usd
us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
135 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13021 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-121649 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
371250 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
297500 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
155000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
436969 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
742474 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1500025 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1727279 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1588695 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3146028 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1151726 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1572426 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-889149 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2100543 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1527391 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
528117 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
638242 usd
us-gaap Interest Paid Net
InterestPaidNet
79314 usd
JTAI Subscription Receivable From Sale Of Common Stock
SubscriptionReceivableFromSaleOfCommonStock
25479 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zjkF366D6Svc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
500000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
500000 usd
us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentImpairment_zZhNLKfVerEg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Property and Equipment</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost, less accumulated depreciation. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment are retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. As of June 30, 2024 and December 31, 2023, property and equipment consisted entirely of equipment which is being depreciated over a <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20240630_zqhtOpukYAsd" title="Useful lives::XDX::P3Y"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20231231_zwHkaUJVToSh" title="Useful lives::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0698"><span style="-sec-ix-hidden: xdx2ixbrl0700">three</span></span></span></span>-year period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
398000 usd
CY2023 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
398000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
66351 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
66351 usd
CY2024Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
464452 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3083884 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2792808 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6932482 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4668316 usd
us-gaap Advertising Expense
AdvertisingExpense
549070 usd
us-gaap Advertising Expense
AdvertisingExpense
223708 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zVjy9A1Y7Dk9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concentration of Credit Risk</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash with several major U.S. financial institutions which it believes to be creditworthy. Balances are insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20240630_zZXMHlmr531a" title="Cash FDIC insured amount">250,000</span>. At times, however the Company may maintain balances in excess of the federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
108461 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
108361 usd
CY2024Q2 JTAI Lease Maintenance Reserve
LeaseMaintenanceReserve
689750 usd
CY2023Q4 JTAI Lease Maintenance Reserve
LeaseMaintenanceReserve
689750 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
798211 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
798111 usd
CY2023Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.05 pure
us-gaap Operating Lease Expense
OperatingLeaseExpense
701550 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
550634 usd
CY2024Q2 JTAI Operating Lease Right Of Use Of Asset
OperatingLeaseRightOfUseOfAsset
2576036 usd
CY2023Q4 JTAI Operating Lease Right Of Use Of Asset
OperatingLeaseRightOfUseOfAsset
2576036 usd
CY2024Q2 JTAI Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
1263704 usd
CY2023Q4 JTAI Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
1003547 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1312332 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1572489 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
517733 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
510034 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
760524 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1021330 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1278257 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1531364 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.03 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
274500 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
549000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
503250 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1326750 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
48493 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1278257 usd
CY2024Q3 JTAI Volume Weighted Average Price
VolumeWeightedAveragePrice
6.00
CY2023Q3 us-gaap Prepayment Fees On Advances Net
PrepaymentFeesOnAdvancesNet
625000 usd
CY2024Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
59000000 shares
CY2024Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3284488 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2401046 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2755087 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2289000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3216408 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.48
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y21D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
68080 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.42
JTAI Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted
P10Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
15473 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10.42
JTAI Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Forfietures
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfietures
P9Y6M
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3269015 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.59
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M20D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3659015 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.14
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M13D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3659015 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.14
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M13D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3265402 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.91
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y8M12D
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
25221406 shares
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1779794 usd
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
2899913 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-841375 usd
JTAI Revenue From Current Period Sales
RevenueFromCurrentPeriodSales
-2738866 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1099466 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 JTAI Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q2 JTAI Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-032244-index-headers.html Edgar Link pending
0001493152-24-032244-index.html Edgar Link pending
0001493152-24-032244.txt Edgar Link pending
0001493152-24-032244-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
jtai-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
jtai-20240630_cal.xml Edgar Link unprocessable
jtai-20240630_def.xml Edgar Link unprocessable
jtai-20240630_lab.xml Edgar Link unprocessable
jtai-20240630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable